Financials
- Market Capitalization 13.86 M
- Employee 24
- Founded 2017
- CEO N/A
- Website www.passagebio.com
- Headquarter Delaware, United States
- FIGI BBG00NBK4XF9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.82
ratio cours/chiffre d'affaires
25.52
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4728 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.02 USD | +4.08% | -2.86% | -20.93% | -57.32% | 15.10 M USD | ||
| 4729 | QNCX Quince Therapeutics, Inc. - Common Stock | 17.94 USD | +4.00% | +8.14% | +1829.03% | +891.16% | 14.62 M USD | ||
| 4747 | BLRX BioLineRx Ltd - American Depositary Shares | 3.02 USD | -2.58% | -5.63% | -11.18% | +7.47% | 13.14 M USD | ||
| 4751 | INTS Intensity Therapeutics, Inc. - Common Stock | 4.84 USD | -1.63% | 0.00% | +32.24% | +1366.67% | 13.08 M USD |